Publications
Specialty
Search
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
04/09/2024
The trial focused on patients with angina due to plaque buildup in the coronary arteries that is not adequately controlled with available treatments. The CSR is an hourglass-shaped stent designed to narrow the vein that collects blood from the heart muscle (the coronary sinus) and drive oxygen-rich blood back into areas of the heart muscle that may not be receiving enough blood.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
04/09/2024
REDUCER-I is a post-market, multi-center, observational study designed to collect long-term outcomes on Shockwave Reducer in a large, ‘real-world’ population of 400 patients.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
04/09/2024
A new analysis of data from the PIONEER AF-PCI clinical trial demonstrates that XARELTO® (rivaroxaban) is associated with a reduced risk of clinically significant bleeding (CSB), and net adverse clinical events (NACE; a composite of clinically significant bleeding [CSB] or major adverse cardiovascular event [MACE]) or rehospitalization compared to warfarin among both elderly and non-elderly patients with nonvalvular atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI)
Pharmacy Learning Network
04/09/2024
The United States Court of Appeals for the Federal Circuit has just revived the case of a female pharmacist who claimed gender discrimination after a male pharmacist was hired at a higher pay.
Psych Congress Network
04/09/2024
Jim Phelps, MD: So Julie, you can think about children and adults. The question I would have for you is, do you think there's any way to accurately differentiate things like PTSD, ADHD, and generalized anxiety disorder when they're co-occurring with depression from bipolar mixed states?
Psych Congress Network
04/09/2024
Join Drs Phelps Carbray in an insightful discussion on the complexities of diagnosing and treating mood disorders and delve into their strategies for unraveling these diagnostic dilemmas and crafting informed treatment plans.
Oncology
04/09/2024
According to a phase 1/2 trial, combining mini-hyper-CVD low-intensity chemotherapy with venetoclax yielded safety and activity among patients with heavily pretreated R/R acute lymphoblastic leukemia.
Oncology
04/09/2024
According to phase 2 data, short induction therapy followed by high-dose chemotherapy and autologous hematopoietic stem-cell transplantation is active in select older patients with primary diffuse large B-cell CNS lymphoma.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular, Vascular Disease Management
04/09/2024
Getinge announced Aetna, a leading health insurance benefits company in the United States, issued a Clinical Policy Bulletin (CPB) addressing peripheral vascular stents.
Aetna issued a revised CPB stating that the iCast covered stent system is considered medically necessary for the treatment of iliac arterial occlusive disease. The insurance provider previously designated the medical device as experimental and investigational.
Oncology, Lymphoma, Leukemia & Myeloma Network
04/09/2024
During the 2024 Great Debates & Updates in Hematologic Malignancies meeting, Jessica Altman, MD, argues in favor of using sequential therapy over triplet therapy for patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy.
Oncology
04/09/2024
According to phase 3 data from the KarMMa-3 trial, the CAR T-cell therapy idecabtagene vicleucel demonstrates improved health-related quality of life compared with standard regimens among patients with relapsed/refractory multiple myeloma following previous lines of therapy.
Psychiatry & Behavioral Health, Psych Congress Network
04/09/2024
Harm reduction services for people with SUD demonstrate efficacy, but they continue to encounter social stigma and barriers, according to a poster presentation at the RX and Illicit Drug Summit.
EP Lab Digest
04/09/2024
On April 8, 2024, an international consensus statement on how to treat atrial fibrillation with catheter or surgical ablation is published today in EP Europace, a journal of the European Society of Cardiology (ESC), and presented at EHRA 2024, a scientific congress of the ESC.
EP Lab Digest
04/09/2024
New Orleans, LA – Ochsner Health is proud to bring an advancement in the treatment of heart rhythm disorders to the New Orleans and Gulf South region utilizing a new cardiac ablation procedure, the
EP Lab Digest
04/09/2024
AUSTIN, Texas — Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center became the first in the nation to use a novel pulsed field ablation (PFA) system to treat patients with paroxysmal and persistent atrial fibrillation, a heart arrhythmia that affects millions of people worldwide, after receiving approval by the U.S. Food and Drug Administration.
Podiatry Today, Podiatry
04/09/2024
In a companion to his cover feature, this author expounds on the most important things DPMs should know about amputation and mortality, and how you can use the evidence in your practice.
Oncology, Lymphoma, Leukemia & Myeloma Network
04/08/2024
At the 2024 Great Debates & Updates in Hematologic Malignancies meeting, Ashley Rosko, MD, discusses why the comprehensive health of patients with multiple myeloma should be analyzed to make transplant decisions, rather than only focusing on patient age.
Journal of Invasive Cardiology, CardioVascular
04/08/2024
Video Supplement to "Wire Entanglement to a Retrieve Dislodged Stent From the Proximal Right Coronary Artery" (Clinical Image).
Journal of Invasive Cardiology, CardioVascular
04/08/2024
A 70-year-old woman who was a known diabetic and had hypertension presented with non-ST-elevation myocardial infarction.
Lymphoma, Leukemia & Myeloma Network, Oncology
04/08/2024
At the 2024 Great Debates & Updates in Hematologic Malignancies meeting, Andrew Yee, MD, speaks about mitigating the risks of infection while using BCMA bispecific antibodies as treatment.
Current Issue
September 2024
Volume
Issue
Enter Your E-mail
EMSWorld Newsletter
